Iovance Biotherapeutics shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iovance Biotherapeutics by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.4M | 1.1M | 2.17 |
| 2025-06-30 | $1.1M | 648k | 1.72 |
| 2025-03-31 | $2.2M | 648k | 3.33 |
| 2024-12-31 | $9.1M | 1.2M | 7.40 |
| 2024-09-30 | $9.9M | 1.1M | 9.39 |
| 2024-06-30 | $7.4M | 920k | 8.02 |
| 2024-03-31 | $14M | 955k | 14.82 |
| 2023-09-30 | $7.6M | 35k | 216.85 |
| 2023-06-30 | $6.0M | 850k | 7.04 |
| 2023-03-31 | $4.2M | 686k | 6.15 |
| 2022-12-31 | $5.5M | 864k | 6.39 |
| 2022-09-30 | $4.8M | 510k | 9.34 |
| 2022-06-30 | $5.9M | 530k | 11.04 |
| 2022-03-31 | $7.9M | 475k | 16.65 |
| 2021-12-31 | $12M | 600k | 19.42 |
| 2021-09-30 | $7.9M | 320k | 24.66 |
| 2021-06-30 | $7.8M | 300k | 26.02 |
| 2021-03-31 | $9.3M | 295k | 31.66 |
| 2020-12-31 | $15M | 320k | 46.40 |
| 2020-09-30 | $11M | 340k | 32.92 |
| 2020-06-30 | $9.3M | 340k | 27.45 |
| 2020-03-31 | $11M | 365k | 29.93 |
| 2019-12-31 | $13M | 475k | 27.68 |
| 2019-09-30 | $9.5M | 520k | 18.20 |
| 2019-06-30 | $18M | 751k | 24.52 |
| 2019-03-31 | $8.4M | 880k | 9.51 |
| 2018-12-31 | $11M | 1.2M | 8.85 |
| 2018-09-30 | $15M | 1.3M | 11.25 |
| 2018-06-30 | $11M | 848k | 12.80 |
| 2018-03-31 | $16M | 944k | 16.90 |
| 2017-12-31 | $7.6M | 944k | 8.00 |
| 2017-09-30 | $5.5M | 711k | 7.75 |
| 2017-06-30 | $4.8M | 650k | 7.35 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB